Alaunos Therapeutics's total assets for Q3 2025 were $3.72M, a decrease of -21.35% from the previous quarter. TCRT total liabilities were $921.00K for the fiscal quarter, a -14.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.